Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

Bullboard (NDAQ:IPA)

View:
Comment by wallpaper2on Dec 28, 2023 2:58pm

RE:Dart ...omg you're still out there

Dart..Are you watching IPA's performance?  I'll give you another tip in a few weeks.
Post by wallpaper2on Dec 14, 2023 5:07pm

Dart ...omg you're still out there

And blowing smoke. How is your MLCL stock doing?? You pumped it around a 1000 times a year, sucked everyone in, sold and left the country. Now you are back on here predicting a massive .50 cent pp or ...more  
Post by dart321on Dec 06, 2023 11:42am

Panic Financing

This will allow them to keep the doors open for another two or three months to find additional financing. I suspect if they can find some one to finance them it will likely be a massive dilutive offer ...more  
Post by wallpaper2on Oct 31, 2023 12:21pm

5 or 6 new directors coming onboard..not 2 or 3

AND they all have a big following who will be buyers!!! The upside to this is ridiculous..beyond anyones expectations. Keep watching.
Post by wallpaper2on Oct 27, 2023 12:38pm

You have 2 weeks. Fwiw.

AGM is Nov 9th and 2 or 3 more highly experienced and recognizable industry leaders will replace the remaing 2 original directors. This company appears to possess the ticket to success and wealth ...more  
Post by wallpaper2on Oct 25, 2023 10:23am

Todays game changing news release.

There are many many AI upstart companies out there,  but none can touch what Biostrand/Hyft now offer.  IPA described their $25 million purchase of Biostrand as "The Aquisition of the ...more  
Post by wallpaper2on Oct 23, 2023 12:21pm

Dart

You were the self appointed  expert on MLCL and posted around 1000X per year. It is bankrupt and  HALTED at .005 cents and you predicted dollar$ . IPA wil see $5-$20/share before it ever ...more  
Post by dart321on Oct 11, 2023 12:29pm

Pink Sheets

This is heading to the pink sheets real soon !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Post by wallpaper2on Aug 12, 2023 12:43am

Dart

Out of money by friday in May? A lot of idiots out there. June saw a 47% increase over last June with revenue of  $3.5 million. How does that stack up against your mlcl? Doesn't include their ...more  
Post by bmreedon Jul 26, 2023 5:10pm

Webinar Recap w $IPA CEO Jennifer Bath & Radius Research

Webinar Recap: Immunoprecise Antibodies $IPA w CEO Jennifer Bath - Pitch, Deep Dive and Q&A - https://youtu.be/WJhkiouXF1c   CEO Jennifer Bath discusses IPA's technology platform ...more  
Post by bmreedon Jul 14, 2023 2:47pm

Webinar $IPA CEO Jennifer Bath Wed Jul 19 @ 4PM ET / 1PM PT

Webinar - IPA Therapeutics $IPA w/ CEO Jennifer Bath Wednesday, July 19th at 4pm ET / 1pm PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar/register ...more  
Post by averagepennieson Jul 14, 2023 9:33am

ImmunoPrecise Antibodies Invites Investors and Stakeholders

VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), an AI-driven biotherapeutic research and technology, is delighted ...more  
Post by averagepennieson Jul 07, 2023 9:13am

ImmunoPrecise Reports Financial Results and Recent Business

The Company achieved revenue of $20.7 million during the year ended April 30, 2023, a 6.7% increase from the year ended April 30, 2022. YoY growth increases to 9.0% when adjusting for the effects of ...more  
Post by AveragePennyon Jun 29, 2023 9:42am

IPA to Report Financial Results and Recent Business

Conference Call: Event Date: July 07, 2023 Event Time: 10:30 ET Participant Details: Conference ID: 9236374 Participant Toll-Free Dial-In Number: 1 (888) 550-5658 Participant Toll Dial-In ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities